Is pericoital or peri-insemination preexposure prophylaxis effective human immunodeficiency prevention for vaginal exposures?

Seidman, Dominika L; Weber, Shannon; Grant, Robert M

Seidman, Dominika L; Weber, Shannon; Grant, Robert M.

Afiliación

Seidman DL; Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco, San Francisco, CA.
Weber S; Family & Community Medicine, University of California San Francisco, HIVE, University of California San Francisco, Zuckerberg San Francisco General Hospital, 1001 Potrero Ave, Ward 6D, San Francisco, CA 94110. Electronic address: Shannon.weber@ucsf.edu.
Grant RM; School of Medicine, University of California San Francisco, Gladstone Institutes, San Francisco, CA.

Am J Obstet Gynecol ; 217(2): 230-231, 2017 08.

Article en En | MEDLINE | ID: mdl-28479285

Asunto(s)

Fármacos Anti-VIH; Profilaxis Pre-Exposición; Femenino; Infecciones por VIH; Humanos; Inseminación

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fármacos Anti-VIH / Profilaxis Pre-Exposición Límite: Female / Humans Idioma: En Revista: Am J Obstet Gynecol Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google